Table 3.
Inclusion criteria used to evaluate publications in this review.
| Abou-Donia et al. (2008) | Tanaka (2012a) | Tanaka (2012b) | Ozdemir et al. (2014) | Crosby et al. (2015) | ||
|---|---|---|---|---|---|---|
| In vivo studies | English; full article with data tables | Yes | Yes | Yes | Yes | Yes |
| Single chemical: Not a mixture or formulation | Yes | Yes | Yes | Yes | Yes | |
| Chemical conc. and dose levels reported | Yes | Yes | Yes | No/Yes | Yes | |
| Explicit duration of exposure | Yes | Yes | Yes | Yes | Yes | |
| Distinguish DNT from acute neurotoxic effect | Yes | Yes (GD0–LD21) | No (repro study) | No (PND 7 to term) | Yes | |
| Appropriate concurrent control for reference | Yes | Yes | Yes | Yes | Yes | |
| Test organism and sample size defined | Yes | Yes | Yes | Yes | Yes | |
| Relevant to human risk for DNT | Yes | Yes | Yes | Yes | Unknown |
| In vitro studies | Kimura-Kuroda et al. (2012) | |
| English; full article with data tables | Yes | |
| Findings relevant to DNT outcomes | Yes |